Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the Price/OCF ratio high or low?
The Price/OCF ratio of 0.54 is 27% below its estimated 1-year average of 0.74, near the low end of its estimated 1-year range (0.54–0.91).
As of 2026-10-06T16:42:02.330Z.
Calculation as of: 2026-10-06T16:42:02.330Z.
Quote observation: 2026-10-06T16:37:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9199062e3d99303b6ceeba444dd11ff94fafae694fd5228a7a2e61ab73072144
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
0.54
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
16.37
median of 218 covered companies
CURRENT VS SECTOR MEDIAN
-96.70%
vs the sector median at left
Market Cap
$69.31M
Price/OCF Ratio
N/A
TTM Avg
338.69
3Y Avg
338.69
5Y Avg
338.69
Market Cap
$69.48M
Price/OCF Ratio
3.55
TTM Avg
11.66
3Y Avg
7.19
5Y Avg
7.76
Market Cap
$70.30M
Price/OCF Ratio
N/A
TTM Avg
15.38
3Y Avg
92.53
5Y Avg
55.53
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | $68.44M | 0.54 | N/A | N/A | N/A |
| iBio, Inc. (IBIO)vs › | $68.62M | N/A | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $69.31M | N/A | 338.69 | 338.69 | 338.69 |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.48M | 3.55 | 11.66 | 7.19 | 7.76 |
| Champions Oncology, Inc. (CSBR)vs › | $70.30M | N/A | 15.38 | 92.53 | 55.53 |
| Cingulate Inc. (CING)vs › | $65.46M | N/A | N/A | N/A | N/A |
| RenovoRx, Inc. (RNXT)vs › | $65.33M | N/A | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.02M | N/A | 35.67 | 35.67 | 35.67 |
| Gain Therapeutics, Inc. (GANX)vs › | $72.51M | N/A | N/A | N/A | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | N/A | 44.68 | 44.68 | 44.68 |
P/OCF Ratio
0.5
P/FCF Ratio
0.5
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2026-10-05 | 0.61 |
| 2026-10-02 | 0.60 |
| 2026-10-01 | 0.61 |
| 2026-09-30 | 0.63 |
| 2026-09-29 | 0.65 |
| 2026-09-28 | 0.64 |
| 2026-09-25 | 0.67 |
| 2026-09-24 | 0.67 |
| 2026-09-23 | 0.69 |
| 2026-09-22 | 0.72 |
| 2026-09-21 | 0.71 |
| 2026-09-18 | 0.74 |
| 2026-09-17 | 0.74 |
| 2026-09-16 | 0.72 |
| 2026-09-15 | 0.73 |
| 2026-09-14 | 0.74 |
| 2026-09-11 | 0.74 |
| 2026-09-10 | 0.76 |
| 2026-09-09 | 0.77 |
| 2026-09-08 | 0.80 |
| 2026-09-04 | 0.80 |
| 2026-09-03 | 0.80 |
| 2026-09-02 | 0.80 |
| 2026-09-01 | 0.79 |
| 2026-08-31 | 0.81 |
| 2026-08-28 | 0.81 |
| 2026-08-27 | 0.82 |
| 2026-08-26 | 0.83 |
| 2026-08-25 | 0.83 |
| 2026-08-24 | 0.86 |
| 2026-08-21 | 0.84 |
| 2026-08-20 | 0.81 |
| 2026-08-19 | 0.84 |
| 2026-08-18 | 0.86 |
| 2026-08-17 | 0.83 |
| 2026-08-14 | 0.86 |
| 2026-08-13 | 0.73 |
| 2026-08-12 | 0.67 |
| 2026-08-11 | 0.64 |
| 2026-08-10 | 0.67 |
| 2026-08-07 | 0.65 |
| 2026-08-06 | 0.67 |
| 2026-08-05 | 0.68 |
| 2026-08-04 | 0.66 |
| 2026-08-03 | 0.67 |
| 2026-07-31 | 0.76 |
| 2026-07-30 | 0.80 |
| 2026-07-29 | 0.82 |
| 2026-07-28 | 0.83 |
| 2026-07-27 | 0.80 |
| 2026-07-24 | 0.81 |
| 2026-07-23 | 0.84 |
| 2026-07-22 | 0.87 |
| 2026-07-21 | 0.86 |
| 2026-07-20 | 0.81 |
| 2026-07-17 | 0.82 |
| 2026-07-16 | 0.83 |
| 2026-07-15 | 0.90 |
| 2026-07-14 | 0.91 |
| 2026-07-13 | 0.80 |
| 2026-07-10 | 0.80 |
| 2026-07-09 | 0.80 |
| 2026-07-08 | 0.73 |
| 2026-07-07 | 0.73 |
| 2026-07-06 | 0.72 |
| 2026-07-02 | 0.74 |
| 2026-07-01 | 0.75 |
| 2026-06-30 | 0.75 |
| 2026-06-29 | 0.72 |
| 2026-06-26 | 0.67 |
| 2026-06-25 | 0.74 |
| 2026-06-24 | 0.77 |
| 2026-06-23 | 0.77 |
| 2026-06-22 | 0.75 |
| 2026-06-18 | 0.73 |
| 2026-06-17 | 0.75 |
| 2026-06-16 | 0.71 |
| 2026-06-15 | 0.70 |
| 2026-06-12 | 0.67 |
| 2026-06-11 | 0.67 |
| 2026-06-10 | 0.67 |
| 2026-06-09 | 0.71 |
| 2026-06-08 | 0.69 |
| 2026-06-05 | 0.65 |
| 2026-06-04 | 0.67 |
| 2026-06-03 | 0.64 |
| 2026-06-02 | 0.65 |
| 2026-06-01 | 0.63 |
| 2026-05-29 | 0.68 |
| 2026-05-28 | 0.68 |
| 2026-05-27 | 0.67 |
| 2026-05-26 | 0.66 |
| 2026-05-22 | 0.67 |
| 2026-05-21 | 0.68 |
| 2026-05-20 | 0.65 |
| 2026-05-19 | 0.62 |
| 2026-05-18 | 0.60 |
| 2026-05-15 | 0.59 |
